|
⚲
|
| Sunesis Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001061027 |
| Sale | 2009-04-03 ($15.0 M Offered, $10.0 M Sold) |
| Fund | |
| Phone | 6502663500 |
| Address | 395 Oyster Point Boulevard South San Francisco, 94080 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Matthew Fust | |
| Dayton Misfeldt | |
| Ed Hurwitz | |
| Daniel Swisher | |
| Steven Ketchum | |
| Homer Pearce | |
| James Young | |
| David Stump | |
| Eric Bjerholt |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Lieb Joseph C
✚
|
0.0 | |
|
Lientz James R Jr
✚
|
0.0 | |
|
Lifting Solutions Energy Services Inc.
✚
|
0.0 | |
|
Li-FT Power Ltd.
✚
|
0.0 | |
|
Ligature Rolling Fund, LP - B3
✚
|
0.0 | |
|
Lightspeed Ultimate General Partner XI, Ltd.
✚
|
0.0 | |
|
Lightspeed Venture Partners XI, L.P.
✚
|
0.0 | |
|
Li Hanzhong
✚
|
0.0 | |
|
Li Henry He
✚
|
0.0 | |
|
Lido Uncapped Fourth Quarterly Fund, LP
✚
|
0.0 |